Celularity Inc. has reported its actual financial results for the year ended December 31, 2024. The company's total net revenues increased significantly to $54.220 million, compared to $22.771 million in the previous year. This growth was driven by a rise in product sales, which reached $35.336 million, up from $13.149 million the previous year. Additionally, revenues from licenses, royalties, and other sources grew to $13.744 million from $4.181 million. Despite the increase in revenues, Celularity Inc. continues to face financial challenges, as indicated by its accumulated deficit of $899.683 million, compared to $841.791 million the previous year. These results highlight the company's ongoing efforts to enhance its revenue streams through increased product sales and licensing agreements.